Scolaris Content Display Scolaris Content Display

Vitamin B for treating peripheral neuropathy

This is not the most recent version

view the current version 16 July 2008

References

Additional references

Abresch 2001

Abresch RT, Jensen MP, Carter GT. Health‐related quality of life in peripheral neuropathy. Physical Medicine and Rehabilitation Clinics of North America 2001;12(2):461‐72.

Annane 2004

Annane D, Gunn A, Hughes RAC, Jewitt KM, Miller RG, Moore D, et al. Neuromuscular Disease Group. About the Cochrane Collaboration (Collaborative Review Groups (CRGs)). The Cochrane Library2004, issue 4.

Chaney 1992

Chaney SG. Principles of nutrition II: micronutrients. In: Delvin TM editor(s). Textbook of Biochemistry with Clinical Correlations. New York: Wiley‐Liss, 1992:1115‐47.

Clarke 2001

Clarke M, Oxman AD, editors. Collecting Data. Cochrane Reviewers Handbook 4.1.4 [upated October 2001]; Section 7. In: The Cochrane Library [database on CDROM]. The Cochrane Collaboration. Oxford: Update Software; 2001, Issue 4.

Devathasan 1986

Devathasan G, Teo WL, Mylvaganam A. Methylcobalamin in chronic diabetic neuropathy: a double blind clinical and electrophysiological study. Clinical Trials Journal 1986;23(2):130‐40.

Dukes 2000

Dukes MNG, Aronson JK eds. Meyler's Side Effects of Drugs. 12th Edition. Oxford: Elsevier, 2000.

Dyck 2005

Dyck PJ, Hughes RAC, O'Brien PC. Quantitating overall neuropathic symptoms, impairments and outcomes. In: Dyck PJ, Thomas PK editor(s). Peripheral Neuropathy. 4th Edition. Philadelphia: Elsevier Saunders, 2005:1031‐1053.

Goto 1981

Goto Y, Horiuchi A, Koguri K. Proceedings of the International Symposium on DM Neuropathy and its Treatment. Tokyo, September 18 & 19, 1981.

Greene 1981

Greene DA, Brown MJ, Braunstein SN, Schwartz SS, Asbury AK, Winegrad AI. Comparison of clinical course and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes 1981;30(2):139‐47.

Hillman 1996

Hillman RS. Hematopoietic agents: growth factors, minerals and vitamins. In: Gilman AG, Goodman LS, Gilman A editor(s). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Edition. McGraw‐Hill, 1996:1311‐1340.

Hughes 2002

Hughes RA. Peripheral neuropathy. British Medical Journal 2002;324(7335):466‐9.

Huskisson 1974

Huskisson EC. Measurement of Pain. Lancet 1974;2(7889):1127‐31.

Kraft 1988

Kraft GH. Peripheral neuropathies. In: Johnson EW editor(s). Practical Electromyography. 2nd Edition. Baltimore: Williams and Wilkins, 1988:246‐318.

Lumley 2001

Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2001, Issue 3. [MEDLINE: CD001056]

Mahomed 2002

Mahomed K. Folate supplementation in pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 1.

Marcus 1996

Marcus R, Coulston A. Water‐soluble vitamins: the vitamin B complex and ascorbic acid. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Edition. McGraw‐Hill, 1996:1555‐72.

Olson 1996

Olson R. Water‐soluble vitamins. Principles of Pharmacology Basic Concepts and Clinical Application. Kentucky: Chapman and Hall, 1996:949‐979.

RodriguezMartin 2002

Rodriguez‐Martin JL, Qizilbash N, Lopez‐Arrieta JM. Thiamine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2002, Issue 1.
Table 1. OVID MEDLINE STRATEGY

OVID MEDLINE

OVID MEDLINE

'mp' denotes keyword search in title,abstract,subject heading
' $' denotes truncation
'/' denotes a mesh subject heading
'Exp' denotes explosion of mesh subject heading

1. randomized controlled trial.pt.
2. randomized controlled trials/
3. controlled clinical trial.pt.
4. controlled clinical trials/
5. random allocation/
6. double‐blind method/
7. single‐blind method/
8. clinical trial.pt.
9. exp clinical trials/
10. (clin$ adj25 trial$).tw.
11. ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$ or dummy)).tw.
12. placebos/
13. placebo$.tw.
14. random$.tw.
15. research design/
16. (clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
17. multicenter study.pt.
18. meta analysis.pt.
19. Prospective Studies/
20. Intervention Studies/
21. Cross‐Over Studies/
22. Meta‐Analysis/
23. (meta?analys$ or systematic review$).tw.
24. control.tw.
25. or/1‐24
26. Animal/
27. Human/
28. 26 and 27
29. 26 not 28
30. 25 not 29
31. exp Vitamin B Complex/
32. Vitamin B.mp.
33. Aminobenzoic$.mp.
34. Biotin$.mp.
35. Folic$.mp.
36. Inosit$.mp.
37. Nicotinic$.mp.
38. Niacin$.mp.
39. Pantothenic$.mp.
40. Riboflavin$.mp.
41. Thiamin$.mp.
42. Cobamide$.mp.
43. Cobalamin$.mp.
44. Pyridox$.mp.
45. or/31‐44
46. exp Peripheral Nervous System Diseases/
47. neuropath$.mp.
48. 46 or 47
49. Pain.mp. or exp PAIN/
50. 48 and 49
51. exp Demyelinating Diseases/
52. demyelin$.mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
53. 51 or 52
54. (Guillain and Barre).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
55. (Miller and Fisher).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
56. exp LEPROSY/
57. (Leprosy or Leper$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
58. (Hansen$ and Disease).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
59. or/54‐58
60. Diabetic Neuropathies/
61. (motor and Sensory and Neuropath$ and Heredity).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
62. (Charcot and Marie).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
63. (Dejerine and Sottas).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
64. (Refsum and Syndrome$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
65. (Spastic and Parapleg$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
66. exp "Hereditary Sensory and Autonomic Neuropathies"/
67. (Sensory and autonomic and neuropath$ and heredity).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
68. or/60‐67
69. 48 or 50 or 53 or 59 or 68
70. 45 and 69
71. 30 and 70

Figures and Tables -
Table 1. OVID MEDLINE STRATEGY
Navigate to table in Protocol